At-home FIT screening involves testing stool for amounts of blood too small to see, which can help to diagnose colon cancer ...

Colorectal cancer continues to be one of the leading causes of cancer-related deaths worldwide. However, recent advancements in medical screening have brought new hope in the fight against this deadly ...

Multitarget stool DNA tests — which are becoming more popular in the United States — have shown increased sensitivity over fecal immunochemical tests (FITs) for early colorectal cancer (CRC) screening ...

Investigators aimed to evaluate CRC screening behaviors at a population level, identify determinants of screening adherence, and more.

The use of mailed FIT-DNA kits in community health centers significantly increases colorectal cancer screening, though follow ...

Although considered a single class, fecal immunochemical tests (FITs) vary in their ability to detect advanced colorectal neoplasia (ACN) and should not be considered interchangeable, new research ...

A pragmatic cluster-randomized trial across 8 CHC sites (Boston and Los Angeles) enrolled 5127 adults aged 45–75 years ...

Pharmacy-based CRC screening programs using FIT can improve early detection, especially in underserved communities, with effective follow-up care. Patients prefer digital updates for negative results ...

Patients received either mailed FIT with automated text message outreach from study personnel or mailed FIT-DNA with the ...

Cologuard is a colon cancer screening test you can do at home. It’s a noninvasive, stool-based test that comes in a kit. You use the kit to collect a stool sample. Then you send the sample to a lab ...

SAN DIEGO -- An emphasis on fecal immunochemical testing (FIT) as a screening strategy for colorectal cancer allowed a Veterans Administration (VA) hospital to return to pre-COVID-19 pandemic ...

A potentially life-saving bowel cancer screening test can spot the disease at an early stage at West Herts Teaching Hospital ...